Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4+ T-Cell Responses
- 17 May 2017
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 34 (8) , 1716-1727
Abstract
Purpose Induction of cell-mediated immune (CMI) responses is crucial for vaccine-mediated protection against difficult vaccine targets, e.g., Chlamydia trachomatis (Ct). Adjuvants are included in subunit vaccines to potentiate immune responses, but many marketed adjuvants stimulate predominantly humoral immune responses. Therefore, there is an unmet medical need for new adjuvants, which potentiate humoral and CMI responses. The purpose was to design an oil-in-water nanoemulsion adjuvant containing a synthetic CMI-inducing mycobacterial monomycoloyl glycerol (MMG) analogue to concomitantly induce humoral and CMI responses. Methods The influence of emulsion composition was analyzed using a systematic approach. Three factors were varied: i) saturation of the oil phase, ii) type and saturation of the applied surfactant mixture, and iii) surfactant mixture net charge. Results The emulsions were colloidally stable with a droplet diameter of 150–250 nm, and the zeta-potential correlated closely with the net charge of the surfactant mixture. Only cationic emulsions containing the unsaturated surfactant mixture induced concomitant humoral and CMI responses upon immunization of mice with a Ct antigen, and the responses were enhanced when squalene was applied as the oil phase. In contrast, emulsions with neutral and net negative zeta-potentials did not induce CMI responses. The saturation degree of the oil phase did not influence the adjuvanticity. Conclusion Cationic, MMG analogue-containing nanoemulsions are potential adjuvants for vaccines against pathogens for which both humoral and CMI responses are needed.Keywords
Funding Information
- Innovation Fund Denmark (069-2011-1, 09-067052)
- eu (280873)
This publication has 34 references indexed in Scilit:
- Vaccine adjuvant formulations: A pharmaceutical perspectiveSeminars in Immunology, 2013
- Synchronization of Dendritic Cell Activation and Antigen Exposure Is Required for the Induction of Th1/Th17 ResponsesThe Journal of Immunology, 2012
- Immunity by formulation design: Induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion methodJournal of Controlled Release, 2011
- Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivoEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Principles of vaccine design—Lessons from natureVaccine, 2010
- Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI responseJournal of Controlled Release, 2010
- Squalene Emulsions for Parenteral Vaccine and Drug DeliveryMolecules, 2009
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological RequirementsPLOS ONE, 2008
- Bridging the knowledge gaps in vaccine designNature Biotechnology, 2007
- The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomesImmunology, 2007